Clinical Trials Directory

Trials / Terminated

TerminatedNCT02323776

Defining the Radiotherapy Dose and Volume Parameters Affecting Postoperative Complications in Esophageal Cancer Patients

Correlation of Radiotherapy-related Features With Postoperative Complications in Patients With Esophageal Cancer Treated With Trimodality Therapy

Status
Terminated
Phase
Study type
Observational
Enrollment
150 (actual)
Sponsor
Maastricht Radiation Oncology · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

The purpose of this study is to identify features of the cumulative dose-volume histogram (DVH) for patients treated with trimodality therapy in oesophageal cancer and correlate these with postoperative complications.

Detailed description

Intention to treat analysis in patients initially assigned to be treated with the trimodality protocol: neoadjuvant chemoradiotherapy followed by surgery. The investigators will retrospectively evaluate several parameters of the treatment planning of patients treated with a preoperative regimen (CROSS regimen 41,4 Gy in 23 fractions or 50, 4 Gy in 28 fractions ): * PTV volume1 * MLD, V30, V20, V15, V10, VS5 (Volume lung less dan 5 Gy)2 (lung toxicity) * MHD, V20, V30, V403 (heart toxicity) * Mean stomach dose, V50 stomach * Mitochondrial DNA if available per patient Pre-existing cardiac,pulmonary comorbidity, smoking behavior, BMI, type of surgery and chemotherapy (especially taxanes) will be scored and take into account in a multivariate analysis. The investigators will collect these data and correlate the data with the presence of postoperative complications, time of onset of complications and duration of hospitalization. These latter data are already scored in a prospective manner at the Atrium Medical Center in Heerlen.

Conditions

Interventions

TypeNameDescription
OTHERTrimodality protocolneoadjuvant chemoradiotherapy followed by surgery

Timeline

Start date
2014-12-01
Primary completion
2015-09-01
Completion
2015-12-01
First posted
2014-12-23
Last updated
2016-03-18

Locations

1 site across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT02323776. Inclusion in this directory is not an endorsement.